Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a recruitment closure notice and introduces new navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also updates revision metadata from v3.5.5 to v3.6.0 and modifies the 'Intervention/Treatment' heading accordingly.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision tag updated to v3.5.5, replacing the previous v3.5.4 tag. This indicates a new update release for the page or its underlying platform.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 on the page, indicating a minor administrative update to the entry. No substantive changes to study details or results are evident.SummaryDifference0.0%

- Check37 days agoChange DetectedTaoyuan, Taiwan, 320 has been updated to Taoyuan City, Taiwan, 320. The locality name was updated while preserving the postal code, reflecting an official naming update in the study's location list.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a ClinicalTrials.gov page version refresh without changing the study details shown.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.